Trial
NCT04220476
CIMER: Combined Immunotherapies in Metastatic ER+ Breast Cancer
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Weill Medical College of Cornell University
Collaborators
—
Condition
Breast Cancer
Intervention
Stereotactic Body Radiation Therapy (SBRT) (50GY in 5 fractions)
Why stopped
Initiating a new study with revised Statistics.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-09-21